fakitale Malo ogulitsa EUR mu Stock CAS 1451-83-8 2-Bromo-3-Methylpropiophenone 2-Bromo-1- (3-methylphenyl) Propan-1-One/236117-38-7/59774-06-0/1009- 14-9/705-60-2

Kampani yathu imagogomezera kasamalidwe, kukhazikitsidwa kwa ogwira ntchito aluso, komanso kumanga kwa ogwira ntchito, kuyesetsa kwambiri kuwongolera kuzindikira komanso kuzindikira udindo wa ogwira nawo ntchito.Kampani yathu idapeza Chitsimikizo cha IS9001 ndi Chitsimikizo cha European CE cha Fakitale Yogulitsa EUR mu Stock CAS 1451-83-8 2-Bromo-3-Methylpropiophenone 2-Bromo-1- (3-methylphenyl) Propan-1-One/236117-38 -7/59774-06-0/1009-14-9/705-60-2, Tikukulimbikitsani kuti mugwire momwe takhala tikufunira anzathu mkati mwa bizinesi yathu.Tikukhulupirira kuti muulula kupanga nafe osati zobala zipatso komanso zopindulitsa.Takonzeka kukupatsani zomwe mukufuna.
Kampani yathu imagogomezera kasamalidwe, kukhazikitsidwa kwa ogwira ntchito aluso, komanso kumanga kwa ogwira ntchito, kuyesetsa kwambiri kuwongolera kuzindikira komanso kuzindikira udindo wa ogwira nawo ntchito.Kampani yathu idapeza certification ya IS9001 ndi European CE CertificationChina 1451 83 8 ndi CAS 1451 83 8, Masiku ano zinthu zathu zimagulitsidwa padziko lonse lapansi ndi kunja chifukwa cha chithandizo chanthawi zonse komanso chatsopano chamakasitomala.Timapereka mankhwala apamwamba kwambiri komanso mtengo wampikisano, landirani makasitomala okhazikika komanso atsopano omwe amagwirizana nafe!

1-Bromo-2-methoxy-3-nitro-benzene amagwiritsidwa ntchito ngati wapakatikati wa Eltrombopag.
Eltrombopag, yopangidwa ndi GlaxoSmithKline (GSK) ku UK ndipo pambuyo pake idapangidwa limodzi ndi Novartis ku Switzerland, ndiye woyamba komanso wovomerezeka wa agonist ang'onoang'ono omwe si peptide TPO receptor agonist padziko lapansi.Eltrombopag idavomerezedwa ndi US FDA mu 2008 pochiza idiopathic thrombocytopenic purpura (ITP), komanso mu 2014 pochiza aplastic anemia (AA).Ndiwonso mankhwala oyamba ovomerezedwa ndi US FDA pochiza AA m'zaka 30 zaposachedwa.
Mu december2012, US FDA inavomereza Eltrombopag zochizira thrombocytopenia odwala matenda a chiwindi C (CHC), kuti odwala matenda a chiwindi C ndi osauka matenda chifukwa otsika kupatsidwa zinthu za m`mwazi kuwerenga akhoza kuyamba ndi kusunga interferon zochokera muyezo mankhwala kwa matenda a chiwindi.Pa february3, 2014, GlaxoSmithKline adalengeza kuti FDA idapereka chithandizo chamankhwala chopambana cha Eltrombopag pochiza hemopenia kwa odwala omwe ali ndi chemicalbook aplastic anemia (SAA) omwe sanayankhe mokwanira ku immunotherapy.Pa Ogasiti 24, 2015, US FDA idavomereza Eltrombopag kuti azichiza thrombocytopenia mwa akulu ndi ana azaka za 1 ndi kupitilira omwe ali ndi matenda osachiritsika a immune thrombocytopenia (ITP) omwe alibe yankho lokwanira ku corticosteroids, immunoglobulins kapena splenectomy.Pa january4, 2018, Eltrombopag idavomerezedwa kuti ilembedwe ku China kuti ichiritse primary immune thrombocytopenia (ITP).

Kampani yathu imagogomezera kasamalidwe, kukhazikitsidwa kwa ogwira ntchito aluso, komanso kumanga kwa ogwira ntchito, kuyesetsa kwambiri kuwongolera kuzindikira komanso kuzindikira udindo wa ogwira nawo ntchito.Kampani yathu idapeza Chitsimikizo cha IS9001 ndi Chitsimikizo cha European CE cha Fakitale Yogulitsa EUR mu Stock CAS 1451-83-8 2-Bromo-3-Methylpropiophenone 2-Bromo-1- (3-methylphenyl) Propan-1-One/236117-38 -7/59774-06-0/1009-14-9/705-60-2, Tikukulimbikitsani kuti mugwire momwe takhala tikufunira anzathu mkati mwa bizinesi yathu.Tikukhulupirira kuti muulula kupanga nafe osati zobala zipatso komanso zopindulitsa.Takonzeka kukupatsani zomwe mukufuna.
Malo ogulitsa mafakitale kwaChina 1451 83 8 ndi CAS 1451 83 8, Masiku ano zinthu zathu zimagulitsidwa padziko lonse lapansi ndi kunja chifukwa cha chithandizo chanthawi zonse komanso chatsopano chamakasitomala.Timapereka mankhwala apamwamba kwambiri komanso mtengo wampikisano, landirani makasitomala okhazikika komanso atsopano omwe amagwirizana nafe!